Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Trials & Approvals

Fosun Kite’s NDA Accepted for Second Indication of CAR-T in China
Ascletis Files US IND to Test COVID Antiviral for Monkeypox
Akeso Receives Breakthrough Designation for PD-1/VEGF Bispecific
Everest's Partner Reports mRNA Vaccine Matches Pfizer’s
Zhiyi Bio to Start US Trial of Live Biotherapy for Chemotherapy-Induced Diarrhea
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022